Focused B cell response to recurring gluten motif with implications for epitope spreading in celiac disease-Reference-Cited by-同舟云学术

Focused B cell response to recurring gluten motif with implications for epitope spreading in celiac disease

Published:2022-10 Issue:4 Volume:41 Page:111541
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Zhou Chunyan,Østerbye Thomas,Bach Emil,Dahal-Koirala Shiva,Høydahl Lene S.,Steinsbø Øyvind,Jahnsen Jørgen,Lundin Knut E.A.,Buus Søren,Sollid Ludvig M.,Iversen Rasmus^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference49 articles.

1. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders;Al-Toma;United European Gastroenterol. J.,2019

2. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides;Aleanzi;Clin. Chem.,2001

3. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis;Brochet;Nucleic Acids Res.,2008

4. A curated gluten protein sequence database to support development of proteomics methods for determination of gluten in gluten-free foods;Bromilow;J. Proteomics,2017

5. High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays;Buus;Mol. Cell. Proteomics,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Testing for Celiac Disease: Clinical and Methodological Considerations;Clinical Chemistry;2024-08-05

2. New Insights on Genes, Gluten, and Immunopathogenesis of Celiac Disease;Gastroenterology;2024-06

3. Selective activation of naïve B cells with unique epitope specificity shapes autoantibody formation in celiac disease;Journal of Autoimmunity;2024-06

4. Generation of circulating autoreactive pre-plasma cells fueled by naive B cells in celiac disease;Cell Reports;2024-04

5. HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease;Brain;2024-03-01